Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/26/2025

Allergic Rhinitis Treatment Guidelines

Introduction to Treatment Options

  • The American Academy of Allergy, Asthma, and Immunology recommends loratadine as a preferred second-generation antihistamine due to its favorable safety profile 1
  • Loratadine provides effective relief of the core allergic rhinitis symptoms that patients typically experience 1
  • Antihistamines like loratadine directly block histamine receptors, addressing the primary mediator of allergic symptoms 1

Treatment Algorithm

  • The American Academy of Allergy, Asthma, and Immunology suggests starting with loratadine 10 mg once daily for allergic rhinitis treatment 1
  • If inadequate response after 1-2 weeks, consider adding intranasal corticosteroid, which is more effective than antihistamines alone for full symptom spectrum 1
  • Montelukast may be considered if symptoms remain poorly controlled on antihistamine therapy, or if the patient has concurrent asthma or is aspirin-sensitive 2, 3

Special Considerations

  • In patients with renal impairment, loratadine should be used with caution in severe renal impairment (creatinine clearance <10 mL/min) 2
  • Loratadine is preferred in the elderly due to lack of anticholinergic effects and minimal sedation 1
  • Pregnancy guidelines suggest avoiding all antihistamines if possible, especially in the first trimester; loratadine is FDA Pregnancy Category B if treatment is necessary 2

Mechanism and Evidence

  • Montelukast appears more likely to benefit aspirin-sensitive and specific urticaria patterns, but response is unpredictable 2
  • Do not assume montelukast and loratadine are interchangeable - they work through completely different mechanisms and have different evidence bases for allergic rhinitis 1, 2

REFERENCES

1

Antihistamine Treatment for Allergic Rhinitis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025